163 related articles for article (PubMed ID: 12952977)
1. CD and NMR studies of prion protein (PrP) helix 1. Novel implications for its role in the PrPC-->PrPSc conversion process.
Ziegler J; Sticht H; Marx UC; Müller W; Rösch P; Schwarzinger S
J Biol Chem; 2003 Dec; 278(50):50175-81. PubMed ID: 12952977
[TBL] [Abstract][Full Text] [Related]
2. Peptides and proteins in neurodegenerative disease: helix propensity of a polypeptide containing helix 1 of the mouse prion protein studied by NMR and CD spectroscopy.
Liu A; Riek R; Zahn R; Hornemann S; Glockshuber R; Wüthrich K
Biopolymers; 1999; 51(2):145-52. PubMed ID: 10397798
[TBL] [Abstract][Full Text] [Related]
3. Conformational transitions in peptides containing two putative alpha-helices of the prion protein.
Zhang H; Kaneko K; Nguyen JT; Livshits TL; Baldwin MA; Cohen FE; James TL; Prusiner SB
J Mol Biol; 1995 Jul; 250(4):514-26. PubMed ID: 7542350
[TBL] [Abstract][Full Text] [Related]
4. Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations.
Jackson GS; Hosszu LL; Power A; Hill AF; Kenney J; Saibil H; Craven CJ; Waltho JP; Clarke AR; Collinge J
Science; 1999 Mar; 283(5409):1935-7. PubMed ID: 10082469
[TBL] [Abstract][Full Text] [Related]
5. The charge structure of helix 1 in the prion protein regulates conversion to pathogenic PrPSc.
Norstrom EM; Mastrianni JA
J Virol; 2006 Sep; 80(17):8521-9. PubMed ID: 16912302
[TBL] [Abstract][Full Text] [Related]
6. Autocatalytic conversion of recombinant prion proteins displays a species barrier.
Baskakov IV
J Biol Chem; 2004 Feb; 279(9):7671-7. PubMed ID: 14668351
[TBL] [Abstract][Full Text] [Related]
7. Insight into the PrPC-->PrPSc conversion from the structures of antibody-bound ovine prion scrapie-susceptibility variants.
Eghiaian F; Grosclaude J; Lesceu S; Debey P; Doublet B; Tréguer E; Rezaei H; Knossow M
Proc Natl Acad Sci U S A; 2004 Jul; 101(28):10254-9. PubMed ID: 15240887
[TBL] [Abstract][Full Text] [Related]
8. Scrapie prions: a three-dimensional model of an infectious fragment.
Huang Z; Prusiner SB; Cohen FE
Fold Des; 1996; 1(1):13-9. PubMed ID: 9079359
[TBL] [Abstract][Full Text] [Related]
9. Prion protein conversion in vitro.
Supattapone S
J Mol Med (Berl); 2004 Jun; 82(6):348-56. PubMed ID: 15014886
[TBL] [Abstract][Full Text] [Related]
10. Prion protein fragments spanning helix 1 and both strands of beta sheet (residues 125-170) show evidence for predominantly helical propensity by CD and NMR.
Sharman GJ; Kenward N; Williams HE; Landon M; Mayer RJ; Searle MS
Fold Des; 1998; 3(5):313-20. PubMed ID: 9806936
[TBL] [Abstract][Full Text] [Related]
11. Conformational polymorphism of the amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein.
De Gioia L; Selvaggini C; Ghibaudi E; Diomede L; Bugiani O; Forloni G; Tagliavini F; Salmona M
J Biol Chem; 1994 Mar; 269(11):7859-62. PubMed ID: 7907586
[TBL] [Abstract][Full Text] [Related]
12. Binding of prion proteins to lipid membranes.
Critchley P; Kazlauskaite J; Eason R; Pinheiro TJ
Biochem Biophys Res Commun; 2004 Jan; 313(3):559-67. PubMed ID: 14697227
[TBL] [Abstract][Full Text] [Related]
13. Aggregation and fibrillization of the recombinant human prion protein huPrP90-231.
Swietnicki W; Morillas M; Chen SG; Gambetti P; Surewicz WK
Biochemistry; 2000 Jan; 39(2):424-31. PubMed ID: 10631004
[TBL] [Abstract][Full Text] [Related]
14. Spectroscopic characterization of conformational differences between PrPC and PrPSc: an alpha-helix to beta-sheet transition.
Baldwin MA; Pan KM; Nguyen J; Huang Z; Groth D; Serban A; Gasset M; Mehlhorn I; Fletterick RJ; Cohen FE
Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):435-41. PubMed ID: 7913763
[TBL] [Abstract][Full Text] [Related]
15. DNA converts cellular prion protein into the beta-sheet conformation and inhibits prion peptide aggregation.
Cordeiro Y; Machado F; Juliano L; Juliano MA; Brentani RR; Foguel D; Silva JL
J Biol Chem; 2001 Dec; 276(52):49400-9. PubMed ID: 11604397
[TBL] [Abstract][Full Text] [Related]
16. Structure-function aspects of prion proteins.
Daggett V
Curr Opin Biotechnol; 1998 Aug; 9(4):359-65. PubMed ID: 9720262
[TBL] [Abstract][Full Text] [Related]
17. Autonomous and reversible folding of a soluble amino-terminally truncated segment of the mouse prion protein.
Hornemann S; Glockshuber R
J Mol Biol; 1996 Sep; 261(5):614-9. PubMed ID: 8800210
[TBL] [Abstract][Full Text] [Related]
18. Species barrier in prion diseases: a kinetic interpretation based on the conformational adaptation of the prion protein.
Kellershohn N; Laurent M
Biochem J; 1998 Sep; 334 ( Pt 3)(Pt 3):539-45. PubMed ID: 9729459
[TBL] [Abstract][Full Text] [Related]
19. The key-role of tyrosine 155 in the mechanism of prion transconformation as highlighted by a study of sheep mutant peptides.
Bertho G; Bouvier G; Hoa GH; Girault JP
Peptides; 2008 Jul; 29(7):1073-84. PubMed ID: 18455265
[TBL] [Abstract][Full Text] [Related]
20. Residue-specific mobility changes in soluble oligomers of the prion protein define regions involved in aggregation.
Glaves JP; Ladner-Keay CL; Bjorndahl TC; Wishart DS; Sykes BD
Biochim Biophys Acta Proteins Proteom; 2018 Sep; 1866(9):982-988. PubMed ID: 29935976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
